So which is it
Liraglutide 3 mg (Saxenda, FDA-approved for weight management), an earlier-generation daily GLP-1 injection, demonstrates similar gastrointestinal side effect patterns with diarrhea reported in approximately 21% of patients according to its FDA label
Additionally, the administration of oral GLP-1 drugs requires strict guidance: for example, semaglutide must be taken on an empty stomach in the morning, with no more than 120 mL of water, and patients must wait at least 30 minutes before having breakfast
These cardiovascular benefits likely require sustained, adequate receptor activation across all three targets, raising further questions about whether microdosing preserves them
What happens when too much bacteriostatic water is added
Does improper storage affect research outcomes